ADIAL PHARMACEUTICALS, INC. (ADIL) Net income 2017–2025
ADIAL PHARMACEUTICALS, INC. (ADIL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.0MFY2025 · since FY2017: -$1.1M → -$8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.0M | +39.6% |
| FY2024 | -$13.2M | -157.6% |
| FY2023 | -$5.1M | +59.8% |
| FY2022 | -$12.7M | +34.5% |
| FY2021 | -$19.4M | -78.3% |
| FY2020 | -$10.9M | -26.8% |
| FY2019 | -$8.6M | +26.1% |
| FY2018 | -$11.6M | -920.8% |
| FY2017 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ADIL financial trends
ADIL RevenueADIL Net marginADIL Gross profitADIL Gross marginADIL Operating incomeADIL Operating marginADIL Operating cash flowADIL Free cash flowADIL Capital expendituresADIL Return on equityADIL Stock buybacksADIL Dividends paidADIL Total assetsADIL Total liabilitiesADIL Shareholders’ equityADIL overview →